Ad is loading...
CGFCX
Price
$69.21
Change
-$1.16 (-1.65%)
Updated
Nov 15 closing price
RGAHX
Price
$78.97
Change
-$1.33 (-1.66%)
Updated
Nov 15 closing price
Ad is loading...

CGFCX vs RGAHX

Header iconCGFCX vs RGAHX Comparison
Open Charts CGFCX vs RGAHXBanner chart's image
American Funds Growth Fund of Amer 529C
Price$69.21
Change-$1.16 (-1.65%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R5E
Price$78.97
Change-$1.33 (-1.66%)
VolumeN/A
CapitalizationN/A
CGFCX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CGFCX vs. RGAHX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGFCX is a StrongBuy and RGAHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
CGFCX (298B) and RGAHX (298B) have equal amount of cash in the bank . RGAHX pays higher dividends than CGFCX: RGAHX (0.64) vs CGFCX (0.00). CGFCX was incepted earlier than RGAHX: CGFCX (23 years) vs RGAHX (9 years). CGFCX (31.00) and RGAHX (31.00) have comparable annual turnover. CGFCX (250) and RGAHX (250) have matching initial minimum investment requirements. RGAHX annual gain was more profitable for investors over the last year : 28.11 vs. CGFCX (25.84). RGAHX return over 5 years is better than : 53.44 vs. CGFCX (44.46).
CGFCXRGAHXCGFCX / RGAHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years9 years-
Gain YTD25.60826.65696%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets298B298B100%
Annual Yield % from dividends0.000.64-
Returns for 1 year25.8428.1192%
Returns for 3 years-8.49-4.25200%
Returns for 5 years44.4653.4483%
Returns for 10 years53.87N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WEYS38.891.07
+2.83%
Weyco Group
IDA117.190.45
+0.39%
IDACORP
SYY74.95-0.01
-0.01%
Sysco Corp
COLL29.58-0.69
-2.28%
Collegium Pharmaceutical
LEXX2.01-0.11
-5.19%
Lexaria Bioscience Corp